<!DOCTYPE html>
<html lang="en">
<head>
   <meta charset="UTF-8">
   <meta http-equiv="X-UA-Compatible" content="IE=edge">
   <meta name="viewport" content="width=device-width, initial-scale=1.0">
   <title>Contact Us</title>
   <link rel="stylesheet" href="reset.css">
   <link rel="stylesheet" href="main.css">
   <link rel="preconnect" href="https://fonts.googleapis.com">
   <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
   <link href="https://fonts.googleapis.com/css2?family=Audiowide&family=Comfortaa:wght@700&display=swap" rel="stylesheet">
</head>
<body>
   <div class="wrapper">
      <header>
         <h1>Platefuse</h1>
         <h2>Safer, Long-Lasting Platelet Storage Method</h2>
      <nav class="topnav">
         <ul>
            <li><a href="index.html">Home</a></li>
            <li><a href="contact.html">Contact Us</a></li>
         </ul>
      </nav>
      </header>
      <main class="homepage">
         <section class="cancelas">
            <h2>Dr. Cancelas</h2>
               <p>Jose A. Cancelas, MD, PhD, is director of Hoxworth Blood Center, Stem Cell Biology Program leader and director of the Translational Core Laboratories at Cincinnati Children’s Hospital; Professor of Pediatrics, University of Cincinnati.</p>

               <p>You can contact him <a href=”mailto:jose.cancelas@uc.edu”>&#x2709;e-mail link</a></p>
         </section>

         <section class="picture">
            <img src="images/reducedsizeboth.jpg" alt="both researchers">
         </section>

         <section class="zheng">
            <h2>Dr. Zheng</h2>
               <p>Yi Zheng, PhD, is the director of Experimental Hematology, Institute Co-Executive director Cancer and Blood Diseases Institute and Professor, University of Cincinnati Department of Pediatrics</p>

               <p>You can contact him <a href=”mailto:yi.zheng@cchmc.org”>&#x2709;e-mail link</a></p>
         </section>

         <section class="goals">
            <h2>Our goal</h2>
               <p>Now that our method is patented our goal is to help move the product development process along, find strategic partners for investment, and ultimately provide clinical impact.</p>

               <p>Ultimately, obtaining U.S. Food and Drug Administration approval also will require human-cell toxicology testing in a GMP-certified lab, plus planning and performing phase I and II clinical trials.</p>

               <p>Our final objective is to prevent unnecessary waste of vital resources increasing platelets shelf life. Our method will transform blood banking as it will help with unpredictable situations of platelet shortages with a more stable inventory that could then be available for all patients in need.</p>
         </section>
      </main>
      <footer>
         <h3>Safer, Long-Lasting Platelet Storage Method</h3>
      </footer>
   </div>
</body>
</html>